Explore STADA
Sustainability
Healthcare comes with responsibility. STADA’s 2025 Sustainability Report shows our progress on ESG, product safety and patient well-being.
Global STADA+ Day
Entrepreneurial thinking drives innovation. At Global STADA+ Day, teams pitch business cases with start-up spirit - for people’s health.
Nizoral Care wins 2026
Two Nizoral Care products named “Product of the Year 2026” in Italy - recognizing consumer trust and innovation in scalp care.
Latest press releases
For media and investors
STADA LinkedIn
Latest insights from our colleagues
Consumer Healthcare products
Improving access to life-changing treatments for patients worldwide
Speciality Pharmaceuticals are medicines that give patients access to innovative treatment options, especially for chronic, severe or rare diseases.
STADA's Specialty portfolio includes innovative treatments for conditions such as Parkinson’s disease and a rare kidney disease, as well as a range of biologic medicines across uses in cancer, eyecare and autoimmune conditions.
Through partnerships, we are establishing a sustainable specialty pipeline to deliver on our purpose of “Caring for People's Health as a Trusted Partner”.
Affordable generics have been the backbone of STADA since 1895
As a major player in the generics sector, we support patient care with affordable medicines. This is especially true in Europe, where STADA ranks as the fourth-largest manufacturer and supplier of generics in terms of sales.
Seven out of ten medicines prescribed in Europe are generic, but these account for only about 30% of all pharmaceutical expenditure.
Our purpose is ‘Caring for People’s Health as a Trusted Partner
At STADA, this purpose unites all employees globally as a One STADA team with the aim of bringing health to society. It guides STADA's people in their day-to-day business –
and drives the company’s ambition to be the partner of choice in Consumer Healthcare, Generics and Specialty.
